Plasma cell-free DNA and its DNA integrity as biomarker to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate-specific antigen-Reference-Cited by-同舟云学术

Plasma cell-free DNA and its DNA integrity as biomarker to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate-specific antigen

Published:2013-06-19 Issue:4 Volume:45 Page:1023-1028
ISSN:0301-1623
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Feng Jiang,Gang Feng,Li Xiao,Jin Tang,Houbao Huang,Yu Cao,Guorong Li

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s11255-013-0491-2.pdf

Reference20 articles.

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300

2. Strope SA, Andriole GL (2010) Prostate cancer screening: current status and future perspectives. Nat Rev Urol 7:487–493

3. Porcaro AB, Migliorini F, Romano M et al (2010) Investigative clinical study on prostate cancer: on the role of the pretreatment total PSA to free testosterone ratio in selecting different biology groups of prostate cancer patients. Int Urol Nephrol 42:673–681

4. Heijnsdijk EA, der Kinderen A, Wever EM et al (2009) Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer. Br J Cancer 101:1833–1838

5. Wang BG, Huang HY, Chen YC et al (2003) Increased plasm DNA integrity in cancer patients. Cancer Res 63:3966–3968

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid Biopsies Based on Cell-Free DNA Integrity as a Biomarker for Cancer Diagnosis: A Meta-Analysis;Diagnostics;2024-07-09

2. The Potential of Cell-Free DNA in Cancer: towards Standardization and Optimization for Enhanced Diagnosis and Monitoring;J BIOL REG HOMEOS AG;2024

3. Targeted Sequencing of Human Satellite 2 Repeat Sequences in Plasma cfDNA Reveals Potential Breast Cancer Biomarkers;Diagnostics;2024-03-13

4. How to Integrate Prostate Cancer Biomarkers in Urology Clinical Practice: An Update;Cancers;2024-01-11

5. Examining the Relationship and Prognostic Significance of Cell-Free DNA Levels and the PSMA-Positive Tumor Volume in Men with Prostate Cancer: A Retrospective–Prospective [⁶⁸Ga]Ga-PSMA-11 PET/CT Study;Journal of Nuclear Medicine;2023-11-30